论文部分内容阅读
本文选择 5 2例晚期或术后复发、转移的胃癌 ,男 35例 ,女 17例。全部病理证实 ,以 X线、B超或 CT等阳性症状作为评价化疗标准。35例静脉给药 :每次 CF 30 0 mg+ 5 - Fu 5 0 0 mg～ 75 0 mg,iv,连续 5 d为一疗程 ,10例由腹股沟淋巴结灌注给药 ,每次 CF30 0 m g+ 5 - Fu5 0 0 m g～ 75 0 m g+顺铂 (DDP) 80 mg。 7例由腹腔给药 ,剂量同淋巴结给药。结果完全缓解 (CR) 1例 ,部分缓解 (PR) 2 6例 ,稳定 (S) 2 3例 ,进展 (P) 3例 ,总有效率为 5 1.9%。
This article selected 52 cases of advanced or postoperative recurrence, metastasis of gastric cancer, 35 males and 17 females. All histopathologically confirmed, X-ray, B-ultrasound, or CT positive symptoms were used as evaluation criteria for chemotherapy. 35 cases of intravenous administration: Each CF 30 0 mg + 5 - Fu 500 mg ~ 75 0 mg, iv, for 5 days as a course of treatment, 10 cases of inguinal lymph node infusion administration, each CF30 0 m g + 5 - Fu5 0 mg ~ 75 0 m g + cisplatin (DDP) 80 mg. Seven patients were given intraperitoneally and dosed with lymph nodes. The results were complete remission (CR) in 1 case, partial remission (PR) in 26 cases, stable (S) in 23 cases, progress (P) in 3 cases, and the total effective rate was 51.9%.